Clinical trial

GSK1349572 Drug Interaction Study With Efavirenz

NCT01098526

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-16

PhasePHASE1

Study timeline

Study start (actual)2010-03-16Date precision: day

Registry last updated2017-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Infections, Human Immunodeficiency Virus and Herpesviridaeunresolved

Interventions

GSK1349572DRUG

EfavirenzDRUG · verified · RxNorm: efavirenz

Sponsors & collaborators

ViiV Healthcarelead sponsor

Shionogicollaborator

GlaxoSmithKlinecollaborator

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01098526 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.